Under the license agreement with Chugai Pharmaceutical Co., Ltd, Lilly has worldwide development and commercialization rights to orforglipron
The most common side effects of semaglutide are: Nausea Vomiting Diarrhea Stomach pain Constipation Disclaimer: Ozempic and WeGovy are registered trademarks of Novo Nordisk
Available in 10mg and 20mg
In March 2026, Hims settled with Novo Nordisk and exited compounded semaglutide for new patients, pivoting to branded Wegovy and Zepbound.[7] The platform now offers injectable Wegovy at $299/month, oral Wegovy at $249/month, and Zepbound at $399/month, with commercial insurance bringing costs to $0$25/month for eligible patients
For those searching for 'GLP-1 experience' or 'GLP-1 forum' discussions, I'd emphasize the importance of listening to your body, working closely with your healthcare provider, and finding a supportive community
GLP-1 medications significantly suppress appetite, which can lead to inadequate protein consumption during rapid weight loss